| (1) |
Cancer facts and figures. Atlanta: American Cancer Society,
1995. |
| (2) |
Robbins J, Merino MJ, Boice JD Jr, et al. Thyroid cancer:
a lethal endocrine neoplasm. Ann Intern Med 1991; 115: 133-47. |
| (3) |
Mazzaferri EL, Jhiang SM. Long-term impact of initial
surgical andmedical therapy on papillary and follicular thyroid cancer.
Am J Med 1994; 97: 418-28. [Erratum, Am J Med 1995; 98: 215.] |
| (4) |
Maxon HR III, Smith HS. Radioiodine-131 in the diagnosis
and treatment of metastatic well differentiated thyroid cancer. Endocrinol
Metab Clin North Am 1990; 19: 685-718. |
| (5) |
Goldman JM, Line BR, Aamodt RL, Robbins J. Influence
of triiodothyronine withdrawal time on 131I uptake postthyroidectomy for
thyroidcancer. J Clin Endocrinol Metab 1980; 50: 734-9. |
| (6) |
Ozata M, Suzuki S, Miyamoto T, Liu RT, Fierro-Renoy
F, DeGroot LJ. Serum thyroglobulin in the follow-up of patients treated
with differentiated thyroid cancer. J Clin Endocrinol Metab 1994; 79: 98-105. |
| (7) |
Pacini F, Pinchera A, Giani C, Grasso L, Baschieri L.
Serum thyroglobulin concentrations and 131I whole body scans in the diagnosis
of metastases from differentiated thyroid carcinoma (after thyroidectomy).
Clin Endocrinol (Oxf) 1980; 13: 107-10. |
| (8) |
Ringel MD, Ladenson PW. Diagnostic accuracy of 131 I
scanning with recombinant human thyrotropin versus thyroid hormone withdrawal
in apatient with metastatic thyroid carcinoma and hypopituitarism. J Clin
Endocrinol Metab 1996; 81: 1724-5. |
| (9) |
Maloof F, Vickery AL, Rapp B. An evaluation of various
factors influencing the treatment of metastatic thyroid carcinoma with I
131. J Clin Endocrinol Metab 1956; 16: 1-27. |
| (10) |
Sfakianakis GN, Skillman TG, George JM. Thyroxine withdrawal
in thyroid cancer. Ohio State Med J 1975; 71: 79-82. |
| (11) |
Goldberg LD, Ditchek NT. Thyroid carcinoma with spinal
cord compression. JAMA 1981; 245: 953-4. |
| (12) |
Sturgeon CT, Davis FE, Catz B, Petit D, Starr P. Treatment
of thyroid cancer metastases with TSH and I 131 during thyroid hormone medication.
J Clin Endocrinol Metab 1953; 13: 1391-407. |
| (13) |
Benua RS, Sonenberg M, Leeper RD, Rawson RW. An 18 year
study of the use of beef thyrotropin to increase I 131 uptake in metastatic
thyroid cancer. J Nucl Med 1964; 5: 796-801. |
| (14) |
Szkudlinski MW, Thotakura NR, Bucci I, et al. Purification
and characterization of recombinant human thyrotropin (TSH) isoforms produced
by Chinese hamster ovary cells: the role of sialylation and sulfation in
TSH bioactivity. Endocrinology 1993; 133: 1490-503. |
| (15) |
Thotakura NR, Desai RK, Bates LG, Cole ES, Pratt BM,
Weintraub BD. Biological activity and metabolic clearance of a recombinant
human thyrotropin produced in Chinese hamster ovary cells. Endocrinology
1991; 128: 341-8. |
| (16) |
Huber GK, Fong P, Concepcion ES, Davies TF. Recombinant
human thyroid-stimulating hormone: initial bioactivity assessment using
human fetal thyroid cells. J Clin Endocrinol Metab 1991; 72: 1328-31. |
| (17) |
Braverman LE, Pratt BM, Ebner S, Longcope C. Recombinant
human thyrotropin stimulates thyroid function and radioactive iodine uptake
in the Rhesus monkey. J Clin Endocrinol Metab 1992; 74: 1135-9. |
| (18) |
Meier CA, Braverman LE, Ebner SA, et al. Diagnostic
use of human recombinant thyrotropin in patients with thyroid carcinoma
(phase I/IIstudy). J Clin Endocrinol Metab 1994; 78: 188-96. |
| (19) |
Cole ES, Lee K, Lauziere K, et al. Recombinant human
thyroid stimulating hormone: development of a biotechnology product for
detection of metastatic lesions of thyroid carcinoma. Biotechnology 1993;
11: 1014-24. |
| (20) |
Benotti J, Benotti N, Pino S, Gardyna H. Determination
of total iodine in urine, stool, diets, and tissue. Clin Chem 1965; 11:
932-6. |
| (21) |
Billewicz WZ, Chapman RS, Crooks J, et al. Statistical
methods applied to the diagnosis of hypothyroidism. Q J Med 1969; 38: 255-66. |
| (22) |
Shacham S. A shortened version of the Profile of Mood
States. J Pers Assess 1983; 47: 305-6. |
| (23) |
Park S-G, Reynolds JC, Brucker-Davis F, et al. Iodine
kinetics during I-131 scanning in patients with thyroid cancer: comparison
of studies with recombinant human TSH (rhTSH) vs. hypothyroidism. J Nucl
Med 1996; 37: Suppl: 15P. abstract. |
| (24) |
Park H-M, Perkins OW, Edmondson JW, Schnute RB, Manatunga
A. Influence of diagnostic radioiodines on the uptake of ablative dose of
iodine-131. Thyroid 1994; 4: 49-54. |
| (25) |
Guimaraes V, DeGroot LJ. Moderate hypothyroidism in
preparation for whole body 131-I scintiscans and thyroglobulin testing.
Thyroid 1996; 6: 69-73. |